Bioarctic: FDA-ansökan för doseringsform av lecanemab slutförd

Bioarctic: FDA-ansökan för doseringsform av lecanemab slutförd

Bioarctics partner Eisai har slutfört sin stegvisa ansökan till amerikanska läkemedelsverket FDA om marknadsgodkännande (Biologics License Application) av lecanemab för veckovis subkutan underhållsbehandling med en autoinjektor. Det framgår av ett pressmeddelande.

En död av bakterie på McDonalds – tros ha kommit från skivad lök

En död av bakterie på McDonalds – tros ha kommit från skivad lök

En efter en har restaurangbesökare blivit sjuka efter att ha ätit på McDonalds. De flesta av de som blivit sjuka har ätit på McDonalds i Colorado och Nebraska, men totalt handlar det om tio delstater i USA. Minst 49 har rapporterats sjuka av E-coli-bakterier efter att ha ätit på restaurangen, uppger amerikanska hälsomyndigheter. Minst tio har behövt sjukhusvård. I Colorado har en av de som insjuknat, en äldre person, dött efter att ha blivit smittad. Ätit samma hamburgare De som blivit sjuka har alla uppgett att de ätit på McDonalds en kort tid innan de blev sjuka, och de flesta nämnde specifikt hamburgaren "Quarter pounder". Nu tar restaurangkedjan bort hamburgaren från menyn i flera delstater, tillfälligt. – Vi tar livsmedelssäkerheten på största allvar, det är det rätta att göra, uppger McDonalds i ett uttalande. Mycket pekar på att den skivade lök som serveras på hamburgarna är en trolig källa till kontamineringen, enligt en preliminär undersökning gjord av USA:s läkemedelsmyndighet FDA. Samtidigt undersöker USA:s jordbruksdepartement själva biffarna. Fått allvarliga njurkomplikationer E-coli är en grupp bakterier som finns i tarmarna. Ett barn som insjuknat har fått allvarliga njurkomplikationer. – Åtminstone i kött, när man slaktar ett djur, kan man ha kontaminering från de bakterier som finns i tarmarna. E-coli finns i tarmarna. Men också människor som kanske inte har tvättat händerna ordentligt. Det finns hur många sätt du kan få den typen av kontaminering, säger läkaren Celine Gounder i CBS News.

Positiva interimsresultat och möjlighet till accelererat godkännande för Diamyd Medical

Positiva interimsresultat och möjlighet till accelererat godkännande för Diamyd Medical

Läkemedelsbolaget Diamyd Medical, som utvecklar banbrytande behandlingar för typ 1-diabetes, har levererat en rad tunga nyheter på kort tid. Nyligen presenterades mycket positiva resultat från en viktig interimsanalys. Dessutom har bolagets läkemedel fått snabbspårstatus ”Fast Track designation” av den amerikanska läkemedelsmyndigheten FDA, vilket kan påskynda marknadslanseringen. Typ 1-diabetes är en allvarlig autoimmun sjukdom som miljontals […]

FDA på YouTube

FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)

This course aims to prepare clinical investigators to conduct high-quality research, and to acquire a practical understanding of ...

U.S. Food and Drug Administration på YouTube

FDA may ban artificial red dye from beverages and candy

The Food and Drug Administration may finally move to ban artificial red food dye, which is found in beverages, snacks, cereals ...

NBC News på YouTube

FDA moves to pull popular cold and flu medicines from shelves

The FDA is proposing many popular over-the-counter cold and allergy medications be removed from store shelves. The agency ...

TODAY på YouTube

Bernie Sanders Rages At FDA Chief Over Special Interest Groups Harming American Children's Health

During a Senate Health, Education, Labor & Pensions Committee hearing on Thursday, Sen. Bernie Sanders (I-VT) questioned ...

Forbes Breaking News på YouTube

FDA i poddar

“No Evidence of Risk” (FDA Pt. 2)

In 1999, an FDA food investigator found traces of mercury in America’s favorite sweetener. But when she presented her findings, she was told to stop her research. The incident rang alarm bells — was the FDA covering up threats to public health? More recently, the agency’s sources of funding and their role in the Opioid Crisis have drawn suspicion and criticism. Learn more about your ad choices. Visit podcastchoices.com/adchoices

23andMe ft. Anne Wojcicki - How a DNA startup took on the FDA and redefined health tech

Millions of customers have explored their genome with 23andMe. But when the company started in 2006, the idea of consumer DNA testing was heresy to the medical establishment. The FDA once even ordered 23andMe to stop selling its health testing product. The company persevered to make allies out of adversaries, and became the only FDA-approved product on the market. Learn how 23andMe defined the DNA testing category, and used its success to enter the massive new field of drug discovery.    Host: Roelof Botha, Sequoia Capital  Featuring: Anne Wojcicki, Richard Scheller  Transcript: https://www.sequoiacap.com/podcast/crucible-moments-23andMe/ Learn more about your ad choices. Visit podcastchoices.com/adchoices

The rise and fall of a fake decongestant: What phenylephrine tells us about the history of the FDA

The FDA drug approval process is known to be a lengthy and rigorous one. But the FDA-approved ingredient phenylephrine — found in common cold medicines like Sudafed, Mucinex, and NyQuil — was recently found to be no better than a placebo. Phenylephrine has been on store shelves for nearly 90 years. How could that happen?In this episode of Tiny Matters, Sam and Deboki are joined by none other than Deboki's dad, Deb Chakravarti. Deb is a professor with years of industry experience and the current director of the York College FDA Partnership. He helps dissect the FDA's recent findings and how its history and ever-evolving role in the pharmaceutical industry contributed to phenylephrine being used in oral cold medicines for so long.Deb, Deboki and Sam also unpack pharmaceutical ethics cases, like thalidomide in the 1950s and 60s, and the case of Vioxx in the early 2000s, which led to tens of thousands of deaths. Sam and Deboki cap off the episode with tiny show and tells about how the nose is really 2 noses (!) and the story of a new, ingestible, vitamin-sized capsule that could protect people from dying of an opioid overdose, sleep apnea, or other conditions that depress breathing.Check out PNAS Science Sessions here and wherever you listen to podcasts.  Links to the Tiny Show & Tell stories are here and here. Pick up a Tiny Matters mug here! All Tiny Matters transcripts are available here.

A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers. Read this story here. Learn more about your ad choices. Visit megaphone.fm/adchoices

#187 - Ex-FDA Executive Warns Big Pharma is Banning Health Supplements | Daniel Fabricant

Daniel Fabricant, Ph.D served as the Director of the Division of Dietary Supplement Programs at the U.S. Food and Drug Administration (FDA), where he directed agency policy, public affairs and regulatory action regarding regulation of the dietary supplement industry for more than three years. Today Dr. Fabricant is CEO and President of the Natural Products Association (NPA), the nation’s largest and oldest trade organization representing the natural products industry, including dietary supplements, foods, personal care products and more. EPISODE LINKS https://www.npanational.org https://twitter.com/drfabricant FOLLOW DANNY JONES https://www.instagram.com/jonesdanny https://twitter.com/jonesdanny JOIN OUR KULT: https://bit.ly/koncretepatreon OUTLINE 0:00 - Introduction 2:30 - Healthcare in the US 7:55 - How the FDA works 14:33 - Patents / Branded drugs 24:00 - Daniels role at FDA 33:29 - NAC 36:27 - NMN 41:42 - FDA tried to make fish oil a prescription drug 43:24 - Is David Sinclair trying to monopolize NMN? 51:04 - Peptides 1:02:56 - Cannabis & CBD 1:14:32 - Testosterone therapy for men 1:18:50 - FDA pandemic response 1:31:07 - Creatine 1:34:10 - Cancer vaccines 1:40:33 - Universal health care

Closing Bell Overtime: CRISPR Therapeutics CEO On Milestone FDA Approval; Rick Caruso On Potential Macy’s Sale 12/11/23

Major averages notched their third straight positive session. Wells Fargo’s Scott Wren and CFRA’s Sam Stovall break down the market action. Jefferies analyst Brent Thill breaks down Oracle’s revenue miss. Caruso Founder Rick Caruso talks rumors of a Macy’s sale and the broader state of commercial real estate. CRISPR Therapeutics CEO Sam Kulkarni on his company’s partnership with Vertex Pharma leading to breakthrough FDA approval for a sickle cell treatment, the first in US to be approved that uses CRISPR gene-editing technology. 

PT469 – Mason Marks, MD, JD – Drug Policy in 2023: The FDA's Guidance for Clinical Trials, The Natural Medicine Act, and SB-303

In this episode, Joe interviews Mason Marks, MD, JD: drug policy analyst, writer, Professor at the Florida State University College of Law, and senior fellow and project lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. As somewhat of an expert on drug policy and FDA regulation, Marks discusses much of the current legal landscape: What was controversial and most interesting about the FDA’s recent guidance for researchers running clinical trials; how an amendment changed Colorado’s Natural Medicine Act and the odd vibe coming from the rule-making process (very private with canceled meetings and a notable lack of urgency); concerns over Oregon’s confusing program not being sustainable; and how Senate Bill 303 drastically changed confidentiality and how personal data would be collected in the state.  He also discusses the complications and ethics of end-of-life care and psychedelics; the theoretical heart valve risk from chronic use and ways we could research this; the challenge of informed consent; the legal risk of transactions involving people gifting illegal substances; the Gracias Foundation’s recent $16 million grant to Harvard and how people at Harvard feel about psychedelics; and more.  POPLAR, which was founded to essentially change laws around psychedelics, is hosting a conference on February 16 in Manhattan called “Drug Law for the 21st Century,” which will be looking back on 50 years of DEA drug policy and envisioning what could be different going forward. Click here to head to the show notes page. 

Beyond "Abolish The FDA"

“Abolish the FDA” has become a popular slogan in libertarian circles. I’m sympathetic to the spirit of the demand. But a slogan isn’t a plan, and this one is even less of a plan than usual. I used to think that since libertarians always lose, there was no point in having a real plan for what to do if they won. But now that they’ve gone from “literally always lose” to “only lose 99.9% of the time” . . . https://www.astralcodexten.com/p/beyond-abolish-the-fda 

An FDA for AI?

If you’ve listened to some of the dialogue in hearings on Capitol Hill about how to regulate AI, you’ve heard various folks suggest the need for a regulatory agency to govern, in particular, general purpose AI systems that can be deployed across a wide range of applications. One existing agency is often mentioned as a potential model: the Food and Drug Administration (FDA). But how would applying the FDA work in practice? Where does the model break down when it comes to AI and related technologies, which are different in many ways from the types of things the FDA looks at day to day? To answer these questions, Justin Hendrix spoke to Merlin Stein and Connor Dunlop, the authors of a new report published by the Ada Lovelace Institute titled Safe before sale: Learnings from the FDA’s model of life sciences oversight for foundation models.

ThePrintPod: ‘Genetic scissors’ — India using same tech to find sickle cell cure as gene therapy approved by US FDA

FDA-approved Casgevy & Lyfgenia made from patients’ blood stem cells which are modified and given back as single-dose infusion. India ‘in preclinical stage’ of trial of similar therapy.----more----https://theprint.in/health/genetic-scissors-india-using-same-tech-to-find-sickle-cell-cure-as-gene-therapy-approved-by-us-fda/1884468/

(Bonus) FDA Approves Gene Destabilizing Inoculation Revisited, 2024 Cancer Rates are Sky High!!

Show Notes: (Bonus) FDA Approves Mass Extermination Inoculation Revisited, 2024 Cancer Rates are Sky High!! Raw Discussion may be disturbing for some. The Information from 2021 is now very relevant in 2024 now that all of the formerly withheld and censored statistics have now been revealed!!!! {For those who wish to support the show with donations, please send them to :$aigner2019(cashapp) or https://www.paypal.me/Aigner2019 or Zelle(1-617-821-3168).}

BOMBSHELL: Ivermectin Is Now OK To Treat COVID! – Says The FDA

Now that the pharmaceutical industry has made its hundreds of billions from vaccines, and despite an all out smear campaign the agency itself participated in, the Food & Drug Administration has approved the drug Ivermectin as a treatment for COVID. So it turns out that, according to the FDA, it’s OK even if you’re not a horse for you to take Ivermectin to treat your COVID. That’s what you call a win-whinny.  Guest host Craig “Pasta” Jardula, along with Jimmy Dore and Americans’ Comedian Kurt Metzger discuss why Ivermectin had to be so severely demonized during the early days of the pandemic but now can be approved in such a cavalier fashion. Plus a segment on all the terrible jokes late night night comedians made about taking Ivermectin, which has now been approved by the FDA to treat COVID. Also featuring Stef Zamorano and Mike MacRae! And a phone call from Alec Baldwin!